Get started
Author

Emerson Cestari Marino

Observed names: EMERSON CESTARI MARINO, Emerson C Marino, Emerson C. Marino, Emerson Marino, Marino, Emerson
ORCID: 0000-0002-9570-9711
Observed ORCID: 0000-0002-9570-9711
OpenAlex ID: A5012361213
Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial
2017 · Andre Gustavo Daher Vianna, Claudio Silva de Lacerda, et al. · Diabetology & Metabolic Syndrome · 26
PDF
Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12‐week randomized controlled trial
2019 · Andre G. D. Vianna, Claudio S. Lacerda, et al. · Diabetes Obesity and Metabolism · 23
Diagnóstico e tratamento da Cetoacidose Diabética
2023 · Ana Teresa Santomauro, Augusto Cezar Santomauro Jr, et al. · Conectando Pessoas eBooks · 18
A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2 diabetes
2018 · Andre Gustavo Daher Vianna, Claudio Silva Lacerda, et al. · Diabetes Research and Clinical Practice · 18
Rastreio e Controle da Hiperglicemia no Perioperatório
2023 · Emerson Cestari Marino, Leandra Negretto, et al. · Conectando Pessoas eBooks · 12
Screening and management of hospital hyperglycemia in non-critical patients: a position statement from the Brazilian Diabetes Society (SBD)
2025 · Emerson Cestari Marino, Denise Momesso, et al. · Diabetology & Metabolic Syndrome · 10
PDF
Perioperative screening and management of hyperglycemia: a joint position statement from the Brazilian Diabetes Society (SBD), the Brazilian Society of Anesthesiology (SBA) and the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO)
2026 · Emerson Cestari Marino, Leandra Anália Freitas Negretto, et al. · Diabetology & Metabolic Syndrome · 3
Sistemas de infusão contínua de insulina
2026 · Emerson Cestari Marino, Monica A. L. Gabbay, et al. · Conectando Pessoas eBooks · 3
Manejo da síndrome hiperglicêmica hiperosmolar não cetótica (SHHNC)
2025 · Augusto Cezar Santomauro Jr, Ana Teresa Santomauro, et al. · Conectando Pessoas eBooks · 2
Hiperglicemia Hospitalar no Paciente Não-Crítico
2024 · Emerson Cestari Marino, Denise Momesso, et al. · Conectando Pessoas eBooks · 2
Rastreamento e controle da hiperglicemia no perioperatório – posicionamento conjunto da sociedade brasileira de diabetes (SBD), sociedade brasileira de anestesiologia (SBA) e associação brasileira para o estudo da obesidade e síndrome metabólica (ABESO)
2026 · Emerson Cestari Marino, Leandra Anália Freitas Negretto, et al. · Conectando Pessoas eBooks · 1
Hypoglycemia with gliclazide MR in women with type 2 diabetes. A continuous glucose monitoring study
2015 · André Vianna, Laiza Tabisz, et al. · Diabetology & Metabolic Syndrome · 1
PDF
Metas de controle glicêmico
2026 · Bianca de Almeida-Pititto, Monike Lourenço Dias, et al. · Conectando Pessoas eBooks
Monitorização da glicemia capilar, da glicose intersticial (CGM) e cetonemia capilar em pessoas com Diabetes Mellitus
2026 · Emerson Cestari Marino, Wellington Santana da Silva Júnior, et al. · Conectando Pessoas eBooks
Manejo da hiperglicemia hospitalar em pacientes não-críticos
2025 · Emerson Cestari Marino, Denise Momesso, et al. · Conectando Pessoas eBooks
Rastreamento e controle da hiperglicemia no perioperatório
2025 · Emerson Cestari Marino, Leandra Anália Freitas Negretto, et al. · Conectando Pessoas eBooks
Diretrizes clínicas para implantação de programa de controle glicêmico hospitalar
2025 · Denise Momesso, Emerson Cestari Marino, et al. · Conectando Pessoas eBooks
Diagnóstico E Tratamento Das Complicações Crônicas Do Diabetes Mellitus
2022 · ANDRÉ GUSTAVO DAHER VIANNA, CLAUDIA PINHEIRO SANCHES ROCHA, et al.
Author response for "Improved Glycemic Variability and Time in Range with Dapagliflozin versus Gliclazide Modified Release among Adults with Type 2 Diabetes Evaluated by Continuous Glucose Monitoring: A 12‐week Randomized Controlled Trial"
2019 · Andre G. D. Vianna, Claudio S. Lacerda, et al. · Publons reviews and discussion
Author response for "Improved Glycemic Variability and Time in Range with Dapagliflozin versus Gliclazide Modified Release among Adults with Type 2 Diabetes Evaluated by Continuous Glucose Monitoring: A 12‐week Randomized Controlled Trial"
2019 · Andre G. D. Vianna, Claudio S. Lacerda, et al. · Publons reviews and discussion
164-LB: A Randomized Controlled Trial to Compare the Glycemic Effects of Dapagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Gliclazide Modified Release, a Sulfonylurea, Assessed by Continuous Glucose Monitoring among People with Type 2 Diabetes
2019 · ANDRE G.D. VIANNA, CLAUDIO SILVA DE LACERDA, et al. · Diabetes
MOESM1 of Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial
2017 · Vianna, Andre, Lacerda, Claudio, et al. · Figshare
Type 2 diabetes: is there any relation between poor control and bone metabolism?
2015 · André Vianna, Laiza Tabisz, et al. · Diabetology & Metabolic Syndrome
PDF
H 032 Stroke and Diastolic Blood Pressure Associated to Cognitive Dysfunction in Elderly Hypertensive Individuals
2007 · José FV Martin, Renan OV Melo, et al. · Atherosclerosis Supplements
Works count: 24
Citation count: 119
H-index: 6
I10-index: 6
Year
Topic
Type